Karachi, Sanofi – Aventis Pakistan Limited informed Pakistan Stock Exchange that annual general meeting of the company is scheduled to be held on April 23, 2019 at Karachi.
The agenda of the meeting will be confirming the minutes of Annual General Meeting held on April 26, 2018, to receive, consider and adopt the audited financial statements for the year ended December 31, 2018 together with the Directors’ and Auditors’ reports thereon to approve and declare final cash dividend on the ordinary shares of the Company. The Directors have recommended a cash dividend of Rs. 30.00 (300%) per share for the year ended December 31, 2018 which will be payable to the Members whose names appear in the register of the Members on April 16, 2019 close of business, to appoint External Auditors for the year ending December 31, 2019 and to fix their remuneration and to transact any other business with the permission of the Chair.
Further, the closed period of the company is from April 17, 2019 to April 23,
2019 (both days inclusive).
Sanofi – Aventis Pakistan Limited was incorporated in Pakistan in
1997as a Public Limited Corporation. The foundations of the company have been
laid under the Companies Ordnance, 1984. The company is engaged in the
manufacturing and sale of pharmaceutical and consumer products. The shares of
the company are quoted on the Karachi, Lahore and Islamabad Stock Exchanges of
Pakistan. The registered office of the company is located at Karachi.
The site of the company is organized in four specialized and autonomous
business units which aid the company with the manufacturing process. The
manufacturing products of the company range from oral solids and liquid dosage
forms to highly technical and sophisticated sterile products.
The symbol “SAPL” is being used by the stock exchanges for the shares of Sanofi
– Aventis Pakistan Limited.
